An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris
Clinical trial NCT04148287 · COMPLETED
Trial details
- NCT number
- NCT04148287
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-13
- Primary completion
- 2020-11-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.